How is the Elevation Oncology Inc today?

The Elevation Oncology Inc today is trading in the down by 0.00% at 0.32.

What is Elevation Oncology Inc Annual Net Profit?

Elevation Oncology Inc Annual Net Profit rose 2.67% in the last year to $44.48 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is Elevation Oncology Inc Price to Earning Ratio?

Elevation Oncology Inc Price to Earning Ratio is -0.39, which is negative.

What is Elevation Oncology Inc Stock Price?

Elevation Oncology Inc Stock Price fell 91.6% and underperformed its sector by 103.14% in the past year.

What is Elevation Oncology Inc Quarterly Net profit?

Elevation Oncology Inc Quarterly Net profit fell 32.73% YoY to $14.21 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is Elevation Oncology Inc Debt to Equity Ratio?

Elevation Oncology Inc Debt to Equity Ratio of 0.52 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Elevation Oncology Inc Return on Equity(ROE)?

Elevation Oncology Inc Return on Equity(ROE) for the last financial year was -77.48%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Elevation Oncology Inc Mutual Fund Holding?

Elevation Oncology Inc Mutual Fund Holding decreased by 0.42% in the last quarter to 16.87.

What is Elevation Oncology Inc Interest Coverage Ratio?

Elevation Oncology Inc Interest Coverage Ratio is -10.11, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Elevation Oncology Inc Institutional Holding?

Elevation Oncology Inc Institutional Holding increased by 0.56% in the last quarter to 57.67.

Elevation Oncology Inc XNAS: ELEV

Elevation Oncology Inc Live Share Price Today, Share Analysis and Chart

Name: Elevation Oncology Inc: Is Infosys Ltd. worth buying?
Item: Elevation Oncology Inc
Rating: 0.98475
Author: Trendlyne DVM scores

about

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an...

0.32 0.00 (0.00%)

92.61% Fall from 52W High

711.1K XNAS Volume

XNAS 22 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

15.0 / 100

Technically Bearish

24.4 / 100

No estimates available

Elevation Oncology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Elevation Oncology Inc FAQ

How is Elevation Oncology Inc today?

Elevation Oncology Inc today is trading in the red, and is down by 0.00% at 0.32.

How has Elevation Oncology Inc performed historically?

Elevation Oncology Inc is currently trading down 0.00% on an intraday basis. In the past week the stock rose 6.67%. stock has been down -47.54% in the past quarter and fell -91.60% in the past year. You can view this in the overview section.